Janssen files patent infringement trial against Samsung Bioepis
Janssen, a U.S. global pharmaceutical company, filed a patent infringement trial against Samsung Bioepis.
Janssen recently sued Samsung Bioepis for infringing the 3 patents of ‘Remicade’ with the company’s ‘Renflexis’ at the Superior Court of New Jersey.
‘Renflexis,’ a Samsung Bioepis’s autoimm...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
